In my view the American Big Pharma's are too big and they really have no organic growth at this point. Most of them are justing buying whatever growth they have.
The one exception I see is Bristol. After spending the last decade in the toilet, they seem to be in a decent position to roll out some interesting products.
Market Data 
Markets 
AI
